Detalles de la búsqueda
1.
Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
Pediatr Blood Cancer
; 52(2): 242-7, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18985740
2.
Predictors of adherence to triptans: factors of sustained vs lapsed users.
Headache
; 49(3): 386-94, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19220501
3.
Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
Anesth Analg
; 109(2): 418-25, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19608812
4.
Migraine strikes study: factors in patients' decision to treat early.
J Headache Pain
; 10(2): 93-9, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19137240
5.
Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects.
J Clin Pharmacol
; 47(7): 834-40, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17525168
6.
A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
Anesth Analg
; 104(5): 1082-9, tables of contents, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17456656
7.
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
J Clin Oncol
; 21(22): 4112-9, 2003 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14559886
8.
The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
Eur J Cancer
; 41(9): 1278-85, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15939263
9.
Evaluation of potential inductive effects of aprepitant on cytochrome P450 3A4 and 2C9 activity.
J Clin Pharmacol
; 44(3): 215-23, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-14973304
10.
Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
Clin Ther
; 31(8): 1747-53, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19808133
11.
Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant.
Curr Med Res Opin
; 23(10): 2559-65, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17845742
12.
Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials.
Cancer
; 104(4): 864-8, 2005 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15973669
13.
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
Headache
; 42(1): 49-55, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12005275
14.
Aprepitant: an oral NK1 antagonist for the prevention of nausea and vomiting induced by highly emetogenic chemotherapy.
Drugs Today (Barc)
; 40(10): 853-63, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15605119
15.
Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Cancer
; 97(12): 3090-8, 2003 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12784346
16.
The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
Am J Gastroenterol
; 98(8): 1725-33, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12907325
17.
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Cancer
; 97(9): 2290-300, 2003 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12712486
18.
Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Cancer
; 94(11): 3032-41, 2002 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12115394
Resultados
1 -
18
de 18
1
Próxima >
>>